Segall Bryant & Hamill’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,790
Closed -$436K 621
2023
Q2
$436K Buy
6,790
+130
+2% +$7.33K ﹤0.01% 586
2023
Q1
$353K Hold
6,660
﹤0.01% 616
2022
Q4
$279K Sell
6,660
-9,900
-60% -$414K ﹤0.01% 656
2022
Q3
$606K Sell
16,560
-34,330
-67% -$1.53M 0.01% 550
2022
Q2
$2.17M Sell
50,890
-5,240
-9% -$249K 0.02% 414
2022
Q1
$3.02M Buy
56,130
+350
+0.6% +$20.4K 0.03% 396
2021
Q4
$4.01M Buy
55,780
+11,600
+26% +$727K 0.04% 345
2021
Q3
$2.51M Buy
44,180
+38,060
+622% +$2.32M 0.02% 437
2021
Q2
$398K Sell
6,120
-156,950
-96% -$9.91M ﹤0.01% 653
2021
Q1
$9.71M Buy
163,070
+157,940
+3,079% +$8.61M 0.1% 224
2020
Q4
$242K Buy
+5,130
New +$216K ﹤0.01% 687

Other funds holding LRCX

Segall Bryant & Hamill's LRCX Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Lam Research (LRCX) in Q3 2023, closing a stake of 6,790 shares — an estimated $436K sold.

Segall Bryant & Hamill first reported a position in LRCX in Q4 2020 and held it in 11 quarters. The position peaked at $9.71M in Q1 2021. 1,449 funds tracked by Wall St. Rank hold LRCX as of Q3 2023.

  • Segall Bryant & Hamill reported no remaining Lam Research position as of Q3 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 6,790 Lam Research shares in Q3 2023, an estimated $436K.
  • Segall Bryant & Hamill first reported a position in Lam Research in Q4 2020 and held it in 11 quarters.
  • Segall Bryant & Hamill's Lam Research position peaked at $9.71M in Q1 2021.
  • 1,449 funds tracked by Wall St. Rank held Lam Research as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.